Determinants of Local Progression After Computed Tomography-Guided Percutaneous Radiofrequency Ablation for Unresectable Lung Tumors: 9-Year Experience in a Single Institution

2009 ◽  
Vol 33 (4) ◽  
pp. 787-793 ◽  
Author(s):  
Tomohisa Okuma ◽  
Toshiyuki Matsuoka ◽  
Akira Yamamoto ◽  
Yoshimasa Oyama ◽  
Shinichi Hamamoto ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Radiofrequency Ablation ◽  
Lung Tumors ◽  
Percutaneous Radiofrequency Ablation ◽  
Single Institution ◽  
Local Progression

scholarly journals Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors

Cancer ◽  
2006 ◽  
Vol 107 (12) ◽  
pp. 2873-2880 ◽  
Author(s):  
Takao Hiraki ◽  
Jun Sakurai ◽  
Toshihide Tsuda ◽  
Hideo Gobara ◽  
Yoshifumi Sano ◽  
...  
Keyword(s):  
Risk Factors ◽  
Radiofrequency Ablation ◽  
Lung Tumors ◽  
Percutaneous Radiofrequency Ablation ◽  
Local Progression

Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up

2010 ◽  
Vol 34 (5) ◽  
pp. 989-997 ◽  
Author(s):  
Jean Palussière ◽  
Benjamin Marcet ◽  
Edouard Descat ◽  
Frédéric Deschamps ◽  
Pramod Rao ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Radiofrequency Ablation ◽  
Lung Tumors ◽  
Percutaneous Radiofrequency Ablation ◽  
Computed Tomography Imaging ◽  
Tomography Imaging

Leberzellkarzinom – Radiofrequenzablation: Welches Bildgebungsverfahren ist effektiver?

2019 ◽  
Vol 24 (04) ◽  
pp. 163-164
Author(s):  
Cornelia Fietz
Keyword(s):  
Computed Tomography ◽  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Comparative Effectiveness ◽  
Percutaneous Radiofrequency Ablation ◽  
Ultrasound Guided ◽  
Medicare Patients ◽  
Us Dollar

Huo J et al. Comparative Effectiveness of Computed Tomography-Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma. Value Health 2019; 22(3):284–292 Die Inzidenz des Leberzellkarzinoms hat sich in den letzen 20 Jahren mehr als verdoppelt. 2018 wurden in den USA mehr als 31 600 neue Fälle registriert, knapp die Hälfte dieser Patienten war älter als 65 Jahre. Die damit verbundenen jährlichen Kosten werden auf 455 Millionen US Dollar geschätzt. Für fortgeschrittene, inoperable Fälle steht die Radiofrequenzablation als Therapieoption zur Verfügung, die Ultraschall- oder Computertomographie-gestützt durchgeführt werden kann. Die Autoren vergleichen die Effektivität beider Bildgebungstechniken für das Verfahren.

scholarly journals The safety and the efficacy of computed tomography guided percutaneous radiofrequency ablation of osteoid osteoma

2019 ◽  
Vol 53 (5) ◽  
pp. 360-365 ◽  
Author(s):  
Cennet Sahin ◽  
Yunus Oc ◽  
Naim Ediz ◽  
Mustafa Altınay ◽  
Aylin Hasanefendioğlu Bayrak
Keyword(s):  
Computed Tomography ◽  
Radiofrequency Ablation ◽  
Osteoid Osteoma ◽  
Percutaneous Radiofrequency Ablation

Percutaneous Radiofrequency Ablation of Lung Tumors in a Large Animal Model

2003 ◽  
Vol 14 (8) ◽  
pp. 1037-1043 ◽  
Author(s):  
Kamran Ahrar ◽  
Roger E. Price ◽  
Michael J. Wallace ◽  
David C. Madoff ◽  
Sanjay Gupta ◽  
...  
Keyword(s):  
Animal Model ◽  
Radiofrequency Ablation ◽  
Lung Tumors ◽  
Large Animal Model ◽  
Large Animal ◽  
Percutaneous Radiofrequency Ablation

Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702)

2016 ◽  
Vol 34 (8) ◽  
pp. 556-563 ◽  
Author(s):  
Hideo Gobara ◽  
Yasuaki Arai ◽  
Takeshi Kobayashi ◽  
Koichiro Yamakado ◽  
Yoshitaka Inaba ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Phase Ii ◽  
Multicenter Study ◽  
Lung Tumors ◽  
Percutaneous Radiofrequency Ablation ◽  
Prospective Multicenter Study
Sign in / Sign up

Export Citation Format

Share Document